Immutep Limited carries a market capitalization of 53.78M, placing it among publicly traded companies globally. Its enterprise value stands at 4.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 53.78M |
| Enterprise Value | 4.09B |
Immutep Limited currently has 1.45B shares outstanding.
| Shares Outstanding | 1.45B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Immutep Limited maintains a current ratio of 18.25, meaning it holds 18.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 18.25 |
| Quick Ratio | 36.21 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Immutep Limited's stock has declined approximately -77.88485% over the past 52 weeks. The 50-day moving average sits at 0.40, while the 200-day moving average is 1.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | -77.88485% |
| 50-Day Moving Average | 0.40 |
| 200-Day Moving Average | 1.29 |
| Average Volume (20 Days) | N/A |
| Operating Cash Flow | N/A |
| Capital Expenditures | -50,369.00 |
| Free Cash Flow | -50,369.00 |
| FCF Per Share | N/A |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -2.34 |
| FCF Yield | N/A |
Immutep Limited's most recent stock split took place on November 7, 2019 with a 10:1 split ratio.
| Last Split Date | 11/7/2019 |
| Split Ratio | 10:1 |
Immutep Limited posts an Altman Z-Score of 217.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 217.38 |